This inventor holds 1 USPTO granted patent. Top assignee: Santen Pharmaceutical Co., Ltd.. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Masaaki Hayashi: Innovator in Postoperative Astigmatism Prevention.
Introduction
Masaaki Hayashi is a notable inventor based in Ikoma, Japan. He has made significant contributions to the field of ophthalmology, particularly in the prevention of postoperative astigmatism. His innovative approach has the potential to improve patient outcomes following eye surgeries.
Latest Patents
Masaaki Hayashi holds a patent for a groundbreaking invention aimed at reducing postoperative astigmatism. The patent, titled "Reducing postoperative astigmatism," focuses on finding a drug that is effective in preventing this condition. The invention utilizes lactoferrin as an active ingredient, with a preferred dosage form being an ophthalmic solution. The optimal concentration of lactoferrin in this solution ranges from 0.1 to 1.0% (w/v). This patent highlights Hayashi's commitment to advancing medical science and improving surgical results.
Career Highlights
Masaaki Hayashi is associated with Santen Pharmaceutical Co., Ltd., a company renowned for its dedication to eye care and innovative pharmaceutical solutions. His work at Santen has allowed him to collaborate with other experts in the field, further enhancing his contributions to ophthalmology.
Collaborations
Masaaki Hayashi has worked alongside Mitsushi Hikida, a fellow innovator in the field. Their collaboration has fostered an environment of creativity and innovation, leading to advancements in eye care solutions.
Conclusion
Masaaki Hayashi's contributions to the prevention of postoperative astigmatism through his innovative patent demonstrate his dedication to improving patient care in ophthalmology. His work continues to inspire advancements in the field, showcasing the importance of innovation in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
